Following the achievements in science and technology activities, SaVipharm has set strategic goals for the new development period of 2020 - 2025. Accordingly, it will continue to prioritize investment in trained human resources and finance resources for science & technology and R&D activities, and the breakthrough stage is to invest in building the High-tech R&D Center.
BSE has been developing continuously, obtained a stable standing and approved full of financial capa..
AMPHARCO U.S.A Pharmaceutical JSC C is one of the first pharmaceutical companies in Vietnam to be is..
At the same time, Imexpharm is the first pharmaceutical company to have 3 production lines to be iss..
